Methotrexate for Treatment of Tubal Pregnancy.
- Author:
Seung Yeob BAEK
1
;
Cheol Hoon PARK
;
Yong Wook KIM
;
Gil Joong KIM
;
Tae Eung KIM
;
Duck Yeong RO
;
Jae Keun JUNG
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Methotrexate;
Tubal pregnancy
- MeSH:
Alopecia;
Bone Marrow;
Chorionic Gonadotropin;
Dermatitis;
Diagnosis;
Diarrhea;
Female;
Fetal Heart;
Gestational Age;
Gestational Sac;
Gingivitis, Necrotizing Ulcerative;
Humans;
Leucovorin;
Methotrexate*;
Pneumonia;
Pregnancy;
Pregnancy, Tubal*;
Salpingectomy;
Ultrasonography;
Vomiting
- From:Korean Journal of Obstetrics and Gynecology
2003;46(11):2118-2122
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study was to evaluate value of methotretrexate (MTX) in the treatment of tubal pregnancy. METHODS: 28 patients with unruptured tubal pregnancy were treated alternately with four doses of intramuscular MTX (1.0 mg/kg) and four doses of intramuscular citrovorum factor (0.1 mg/kg). Patients considered eligible for MTX treatment of tubal pregnancy were those with unruptured tubal pregnancy
